Filter
311 - 320 of 1423 results
Results for
Factors That Affect Opioid Quality Improvement Initiatives in Primary Care: Insights from Ten Health Systems
Publication
This study of an Opioid Quality Improvement Collaborative can help providers adopt CDC opioid guidelines and improve their prescribing practices.
Abt-led Namibia Project Exceeds Goal for Male Circumcisions
Project
VMMC is an integral component of the Government of the Republic of Namibia’s prevention approach to ending HIV and AIDS. Despite significant effort, VMMC coverage remains low. The population-based self-reported circumcision rate is 36.4 percent among…
Using Behavioral Insights to Market a Workplace Safety Program: Evidence From a Multi-Armed Experiment
Publication
An Abt evaluation found marketing OSHA’s safety consultation service via brochure was effective but incorporating behavioral nudges didn’t increase uptake.
Providing Local Evaluation Support to ACF’s PREP Grantees
Project
With funding from FYSB, ACF’s Office of Planning, Research, and Evaluation (OPRE) contracted with Abt Global and its partner, Child Trends to provide local evaluation support to PREP grantees and to disseminate project information.
PREA Audit System Provides Tool for Auditors to Conduct Sexual Safety Audits
Project
The Department of Justice's PREA standards outline requirements for preventing, detecting, and responding to sexual abuse and sexual harassment in confinement facilities. Each year, hundreds of confinement facilities must be audited for compliance with…
Lump Sum or Recurring: Can Cash Transfers Break the Cycles of Poverty?
Blog
Data from US & international guaranteed income pilots pose critical questions – does an annual lump sum, monthly payments, or a combination best help families?
Spotlight On: Homelessness and Housing Instability in New York City
Spotlight On
Abt draws upon years of national housing experience and expertise to design solutions tailored for New York City.
Evaluating the Cell and Gene Therapy Access Model
Project
The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.